进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本次提供借款事项概述 四川国光农化股份有限公司（以下简称"公司"）于2025年10月24日召开第六届董事会第七次会议，审议 通过了《关于向子公司山西浩之大生物科技有限公司和二级子公司鹤壁全丰生物科技有限公司提供借款 的议案》，同意公司以自有资金继续向浩之大和鹤壁全丰分别提供金额不超过5,000万元的借款，年利 率3.0%（按人民银行公布的最新1年期LPR计算），借款期限从实际借款之日起不超过1年，按季结收利 息。具体内容详见2025年10月25日公司在指定信息披露媒体《证券时报》《证券日报》《中国证券报》 《上海证券报》和巨潮资讯网（www.cninfo.com.cn）上刊登的相关公告（公告编号：2025-071号）。 二、提供借款进展情况 近日，公司与公司二级子公司鹤壁全丰生物科技有限公司（以下简称"鹤壁全丰"） 签订了《借款合 同》，向鹤壁全丰继续提供借款人民币3,000万元。合同主要内容如下： 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002749 证券简称：国光股份 公告编 ...

2月2日，市场早间震荡调整，三大指数盘中均跌超1%。截至午间收盘，上证指数跌1.32%，深证成指跌 1.41%，创业板指跌1.18%。沪深两市半日成交额1.64万亿，较上个交易日缩量2904亿。盘面上热点快速 轮动，全市场3500只个股下跌。 盘面上，电网设备股逆势爆发，双杰电气、三变科技、杭电股份等多股涨停；白酒股拉升走高，皇台酒 业涨停，水井坊涨超7%；影视股早盘走强，横店影视封板；光模块概念反复活跃，通鼎互联涨停；商 业航天概念表现活跃，西部材料涨停。 点评：消息面上，1月30日，国际贵金属市场出现崩盘式跳水，现货黄金盘中最高跌超12%，最终收跌 9.52%，报4865美元/盎司；现货白银盘中一度暴跌36%，最终收跌26.9%，报84.7美元/盎司。卓创资讯 贵金属分析师黄加奇表示，短期来看，贵金属价格或将继续波动震荡。 跌幅方面，在国际贵金属市场剧烈动荡之际，A股有色金属再现跌停潮，白银有色、湖南白银等三十余 股跌停；油气股低开低走，山东墨龙、中曼石油等跌停；农药、化工股震荡下行，中泰化学、鲁西化工 跌停；半导体产业链走弱，普冉股份、明微电子跌超10%，闻泰科技跌停；三大电信运营商集体下挫， 中国移动 ...

每经AI快讯，安道麦A1月29日晚间发布业绩预告，预计2025年归属于上市公司股东的净利润亏损8.73 亿元~12.33亿元。基本每股收益亏损0.529元~0.3746元。上年同期归属于上市公司股东的净利润亏损 29.03亿元。基本每股收益亏损1.2461元。业绩变动主要原因是，销售额公司预计2025年全年销售额以人 民币计算较2024年同比减少0%~3%，以美元计算同比减少1%~4%。销售价格走低；公司落实战略决策 优化产品组合和区域市场布局，并停止销售部分基础化工产品；以及土耳其在2025年第一季度销售额同 比大幅下降。价格持续疲软的主要原因是原药供过于求导致其价格滞留低位区间，加之海外市场普遍高 息，且大宗农产品价格处于低位，使经销商与农户承受压力。 每经头条（nbdtoutiao）——水贝黄金平台"杰我睿"兑付危机调查：40倍杠杆对赌，金价越涨平台越 亏！老板自称"还在深圳"，投资者：兑付方案本金打两折，无法接受 （记者 曾健辉） ...

Core Viewpoint - The company, Jiangshan Chemical, anticipates a significant increase in net profit for the year 2025, projecting a growth of over 50% compared to the previous year, driven by strategic adjustments in product structure and cost management [2][10]. Group 1: Performance Forecast - The company expects to achieve a net profit attributable to shareholders ranging from 480 million to 580 million yuan for 2025, representing an increase of 255.6 million to 355.6 million yuan year-on-year, which translates to a growth rate of 113.90% to 158.47% [2][4]. - The projected net profit, excluding non-recurring gains and losses, is estimated to be between 326 million to 426 million yuan, reflecting a year-on-year increase of 126.3 million to 226.3 million yuan, or a growth of 63.26% to 113.34% [2][4]. Group 2: Previous Year’s Performance - In the previous year, the total profit was reported at 315.73 million yuan [6]. - The net profit attributable to shareholders was 224.40 million yuan [7]. - The net profit after excluding non-recurring gains and losses was 199.68 million yuan [8]. - The earnings per share for the previous year stood at 0.52 yuan [9]. Group 3: Reasons for Performance Increase - The increase in performance is attributed to the company's ongoing adjustments and optimization of its product structure, focusing on high-margin products and key sales areas, while also enhancing cost control measures to improve competitiveness and mitigate market price pressures [10]. - Non-recurring gains are expected to impact the net profit by approximately 154 million yuan, primarily from the company's divestment of shares in Jiangtian Chemical [12].

1月初以来，农药化工板块持续回暖，开启周期修复行情；农业另一子板块生猪养殖却持续回调，短期 或已充分反应业绩悲观预期。资金连续两日逆势净流入农业ETF华夏（516810.SH），或逢低布局修复 行情，以及博弈2月重要政策预期。 东方证券表示，2026年农业是拐点向上的年份，养殖、种植将依次发力，带来板块趋势上行，建议重点 关注。尤其是生猪养殖板块，优质公司持续盈利和分红率提升依然是推动板块长期业绩和估值提升的核 心驱动；近期政策与市场合力推动生猪养殖行业产能去化，助力未来板块业绩长期提升。 农业ETF华夏（516810.SH）被动跟踪中证农业主题指数，农林牧渔+基础化工含量93.64%，前十大权 重股包括牧原股份、温氏股份、海大集团、藏格矿业、盐湖股份、亚钾国际等，牧原股份+温氏股份合 计权重占比近25%。 消息面上，据新浪报道，养殖龙头公司牧原股份传最快2月香港上市。业绩方面，牧原股份2025年业绩 预告显示，第四季度业绩预计中值实现盈利，成本降幅领先行业，体现龙头公司穿越周期的韧性； ...

Core Viewpoint - The overall performance forecast for companies listed on the Beijing Stock Exchange indicates a positive trend, with most companies expecting profit growth, reflecting their ability to seize market opportunities and enhance competitiveness [1][2]. Group 1: Performance Forecasts - Eight companies have disclosed their performance forecasts for 2025, with five expecting profit increases, one anticipating a profit decrease, and two predicting losses [2]. - HaiNeng Technology expects a more than doubling of net profit, with an increase of 213.65% to 236.61% [2]. - Jilin Carbon Valley forecasts a net profit of 180 million to 220 million yuan, representing a year-on-year growth of 92.81% to 135.66% [1][2]. - Longzhu Technology, Wangcheng Technology, and Lintai New Materials anticipate net profit growth of approximately 50%, over 66%, and over 64%, respectively [1][2]. Group 2: Market Demand and Growth Drivers - The growth of companies is driven by both external market improvements and internal capability enhancements [3]. - The overall recovery in industry demand is a significant backdrop, with HaiNeng Technology noting a notable trend towards domestic manufacturing of high-end instruments and the gradual implementation of equipment renewal policies [3]. - Jilin Carbon Valley has experienced continuous sales growth due to the recovering carbon fiber market [3]. - Companies are enhancing their internal growth momentum through ongoing technological innovation, product upgrades, and market expansion [3][4]. Group 3: Cost Pressures and Challenges - Companies forecasting losses or declines attribute their challenges to rising fixed costs, reduced specific revenues, and ongoing adjustments in their respective sectors [5][6]. - Hualing Co. cites significant increases in depreciation expenses due to fixed assets entering full depreciation in 2025 and rising employee compensation costs [5][6]. - Geobijia mentions a decline in overall gross margin due to a lower sales proportion of high-margin specialty glass products and reduced government subsidies compared to the previous year [6]. - YingTai Bio has narrowed its losses significantly through focused product strategies and cost control, but still faces challenges from investment losses and a sluggish market for intermediates [6].

（文章来源：证券日报） 证券日报网讯 1月23日，雅本化学在互动平台回答投资者提问时表示，本公司全资子公司江苏建农控股 的甘肃兰沃科技有限公司近期取得四唑虫酰胺原药登记（登记证号：PD20252901），系国内本土企业 取得的该原药产品首项登记。需说明的是，甘肃兰沃为该产品授权定制加工企业，相关产品将按合作约 定组织生产供应（CDMO），不涉及自产自销及导致市场格局变动的相关情形。产品具体产量、价格涉 及合作商业信息，暂不便披露。未来，公司将持续聚焦工艺升级与产能优化，在合规前提下保证供应链 稳定，以响应客户需求，助力农业绿色发展。 ...

Group 1 - The core viewpoint of the news is that Taihe Co., Ltd. has shown significant financial growth, with a notable increase in revenue and net profit for the period from January to September 2025 [2] - As of January 21, 2025, Taihe's stock price increased by 1.67%, with a trading volume of 123 million yuan, and a net financing buy of -4.77 million yuan [1] - The company has a financing balance of 76.23 million yuan, which accounts for 6.39% of its market capitalization [1] Group 2 - For the period from January to September 2025, Taihe Co., Ltd. achieved an operating income of 3.89 billion yuan, representing a year-on-year growth of 28.69% [2] - The net profit attributable to the parent company reached 367 million yuan, marking a substantial increase of 120.56% compared to the previous year [2] - The company has distributed a total of 270 million yuan in dividends since its A-share listing [3] Group 3 - As of January 9, 2025, the number of shareholders of Taihe Co., Ltd. increased to 11,600, reflecting a growth of 1.97% [2] - The average number of circulating shares per shareholder decreased by 1.93% to 3,288 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 230,200 shares, which is a decrease of 171,700 shares from the previous period [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000525 证券简称：红太阳 公告编号：2026－002 南京红太阳股份有限公司 第十届董事会第九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 南京红太阳股份有限公司（以下简称"公司"）第十届董事会第九次会议于2026年1月20日在南京市高淳 经济开发区古檀大道18号公司会议室以现场与通讯相结合的方式召开。本次会议通知于2026年1月17日 以书面、邮件或通讯等方式发出。本次会议应参加表决董事9名，实际参加表决董事9名。会议由公司董 事长杨一先生主持。公司高级管理人员列席本次会议。会议的召集和召开符合《公司法》和《公司章 程》等有关规定。会议审议并通过了以下议案： 一、审议并通过了《关于公司为控股子公司山东科信提供担保的议案》 公司控股子公司山东科信生物化学有限公司（简称"山东科信"）为满足日常生产经营及流动资金周转的 需求，拟在青岛银行股份有限公司德州市临邑支行办理流动资金贷款1,000万元，期限为1年。公司为该 笔1,000万元贷款提供连带责任保证担保，占公司最近一期经审计净资 ...

Core Viewpoint - The company anticipates that the expiration of patents for some of its agricultural protection products will have a limited overall impact on its business, as it can continue to upgrade products and technologies based on past production experience [1] Group 1: Patent Expiration Impact - Some agricultural protection customers are facing patent expirations, but the company expects the overall impact to be limited [1] - The company believes that the business increment from product and technology upgrades will effectively cover the natural decline in existing business due to patent expirations, thus maintaining overall revenue stability in this segment [1] Group 2: Product and Technology Upgrades - The company can carry out product and technology upgrades with relatively low investment in existing production facilities, significantly lower than the capital expenditure required for new capacity [1] - If substantial investment is needed, customers are willing to share the costs [1]